Dr Kirsty Danielson Read more
Breast reconstruction is an important part of the treatment process for women with breast cancer.
Associate Professor Vyacheslav Filichev Read more
Drug resistance is a serious barrier to the treatment of breast cancer, leading to metastasis and cancer reoccurrences.
Dr Vanessa Lattimore Read more
The ideal strategy for controlling and reducing the social impact of disease is effective prevention.
Dr Gavin Harris Read more
Digital pathology is the reviewing of tissue slides on a computer monitor rather than using microscopes.
Dr Barbara Lipert Read more
The antibody-drug conjugate trastuzumab emtansine (T-DM1; Kadcyla) extends the survival of HER2-positive metastatic breast cancer patients.
Dr Logan Walker Read more
The future of successful genetic screening in New Zealand requires increased sensitivity and specificity of tests, and informed clinical management for high-risk breast cancer families.
Dr Annette Lasham Read more
Early detection of breast cancer recurrence is critical for saving lives. We have identified two molecules, found in the blood of 250 patients at the time of surgery for breast cancer, that were very good at predicting which of these women would have a relapse before five years.
Dr Robert Weinkove Read more
The aim of this novel and ambitious project is to develop potent new vaccines with potential to prevent recurrence of HER2 positive breast cancer.
Dr Dean Singleton Read more
It is now understood that Triple Negative breast cancer has many biologic nuances and a heterogeneity not previously understood.
Professor John Miller Read more
This research team combines leading expertise in synthetic and medicinal chemistry and cancer biology.